Bentham Science Publishers
Bentham Science Publishers is a major publisher of more than 100 peer-reviewed science, technology and medical (STM) journals, along with a rapidly growing collection of eBooks. Since 1993, Bentham Science Publishers has been catering to the information needs of the pharmaceutical, engineering, biomedical and medical research community.781 - 800 of 1920 results
-
-
Frontiers in Anti-Infective Drug Discovery: Volume 8
More LessThis book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The eighth volume of this series features 8 chapters that cover methods for antimicrobial drug discovery (with 2 chapters that focus on genomics) as well as updates on drug development against Helicobacter pylori and emerging coronaviruses, among other interesting topics:
- Eradication of Helicobacter pylori Infection with Non-Bismuth Quadruple Concomitant Therapy
- Drug Discovery Strategies Against Emerging Coronaviruses: A Global Threat
- Opportunities Offered By Fragment-Based Drug Design in Antibiotic Development
- Phage therapy as a Tool for Control of Foodborne Diseases: Advantages and Limitations
- Subtractive Genomics Approaches: Towards Anti-Bacterial Drug Discovery
- Recent Advances in the Discovery of Antimicrobials through Metagenomics
- Phyto-Nano-Antimicrobials: Synthesis, Characterization, Discovery, and Advances
- Aptamers as Anti-infective Agents
-
-
-
Frontiers in Anti-Infective Drug Discovery: Volume 9
More LessThis book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The ninth volume of this series features 5 reviews that cover some aspects of clinical and pre-clinical antimicrobial drug development, with 2 chapters focusing on drugs to treat leishmaniasis and dengue fever, respectively.
- Use of preclinical and early clinical data for accelerating antimicrobial drug development
- Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs
- Scope and limitations on the potent antimicrobial activities of hydrazone derivatives
- Current scenario of anti-leishmanial drugs and treatment
- Dengue hemorrhagic fever: the potential repurposing drugs
-
-
-
21st Century Challenges in Antimicrobial Therapy and Stewardship
Frontiers in Anti-infective Agents: Volume 3
More Less21st Century Challenges in Antimicrobial Therapy and Stewardship addresses selected topics that are of importance in the practice of infectious disease management. The text starts by illustrating the global landscape of antimicrobial drug resistance, which influences antimicrobial use and therapeutic decisions in the clinic. The contributors explain the reasons for the spread of antibiotic resistance, the pharmacology of antibiotics of different classes, innovative drug delivery methods which can improve the efficacy and safety of new drug candidates and achieve targeted drug delivery as well as drug resistance monitoring techniques and issues in the practice of antimicrobial stewardship and infection control.
Key Features:
- 14 organized chapters on several aspects of antimicrobial therapy and stewardship
- Introductory knowledge on global antimicrobial trends
- Coverage of molecular basis of antimicrobial resistance in gram positive, gram negative and fungal microbes
- Focused coverage on new developments in antimicrobial drug development, drug delivery, formulation and diagnostic tools
- Information on unmet needs of patients and clinicians, including the treatment of difficult infections
- Comprehensive coverage of issues in antimicrobial stewardship
21st Century Challenges in Antimicrobial Therapy and Stewardship brings to readers – healthcare administrators, educators, pharmacists, clinicians and students, alike – the knowledge of the molecular basis of antimicrobial drug therapy, drug resistance in pathogens and current practices in antimicrobial stewardship programs. This knowledge, in turn, fosters an awareness among healthcare industry participants to collaborate in an interprofessional environment to combat multidrug resistance.
-
-
-
Frontiers in Anti-infective Drug Discovery: Volume 1
More Less"Frontiers in Anti-Infective Drug Discovery" is an eBook series devoted to publishing the latest and the most important advances in Anti-Infective drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Infective drug design and discovery. Each volume is devoted to the major advances in Anti-Infective drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
-
-
-
Frontiers in Anti-infective Drug Discovery: Volume 2
More Less"Frontiers in Anti-Infective Drug Discovery" is an Ebook series devoted to publishing the latest and the most important advances in Anti-Infective drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Infective drug design and discovery. Each volume is devoted to the major advances in Anti-Infective drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
-
-
-
Frontiers in Anti-infective Drug Discovery: Volume 3
More LessThis ebook series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the ebook series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The third volume of this series features 6 chapters that cover a variety of topics including:
- Drug Discovery for TB
- Therapeutic Limitations due to Antibiotic Drug Resistance
- Applications for Virus Vaccine Vectors in Infectious Disease Research
- NewCastle Disease Virus
- Anti-Infective Therapy Against Leishmaniasis
- Anti-Viral Activity of Proanthocyanidins
-
-
-
Frontiers in CNS Drug Discovery: Volume 1
More Less“Frontiers in CNS Drug Discovery” is an eBook series devoted to publishing the latest and the most important advances in Central Nervous System (CNS) drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in CNS drug design and discovery. Each volume is devoted to the major advances in CNS drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
-
-
-
Frontiers in CNS Drug Discovery: Volume 2
More Less"Frontiers in CNS Drug Discovery" is an eBook series devoted to publishing the latest and the most important advances in Central Nervous System (CNS) drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in CNS drug design and discovery. Each volume is devoted to the major advances in CNS drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
-
-
-
Frontiers in CNS Drug Discovery: Volume 3
More LessFrontiers in CNS Drug Discovery is a book series devoted to publishing reviews which highlight the latest advances in drug design and discovery for disorders of the central nervous system (CNS). Eminent scientists write contributions on all areas of CNS drug design and drug discovery, including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series is essential reading for all pharmaceutical scientists involved in CNS drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The third volume of this series brings reviews on brain tumor treatment, neurodegeneration, hyperalgesia, cholinesterase inhibition and much more.
-
-
-
Frontiers in Cardiovascular Drug Discovery: Volume 1
More Less"Frontiers in Cardiovascular Drug Discovery" is an eBook series devoted to publishing the latest and the most important advances in Cardiovascular drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in cardiovascular drug design and discovery. Each volume is devoted to the major advances in cardiovascular drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
-
-
-
Frontiers in Cardiovascular Drug Discovery: Volume 2
More LessFrontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest and the most important advances in Cardiovascular drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in cardiovascular drug design and discovery. Each volume is devoted to the major advances in cardiovascular drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
-
-
-
Frontiers in Cardiovascular Drug Discovery: Volume 3
More LessFrontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The eBook series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.
The third volume of the series covers the following topics:
- P2Y12 receptor agonists
-Heart failure pharmacotherapy
-Vasopressin and the cardiovascular system
-Cerebral small vessel disease
-Complement blocking therapeutic strategies
-New antiplatelet and anticoagulating agents for gastrointestinal treatments
-
-
-
Frontiers in Cardiovascular Drug Discovery: Volume 4
More LessFrontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The eBook series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.
The fourth volume of the series covers the following topics:
-Aspirin administration
-Adenosine receptor targeting for cardiovascular therapy
-Drug treatment of patients with coronary stenting
-Immunosuppressive drugs in heart transplantation
-PCSK9 inhibition for lowering LDL-C levels.
-
-
-
Frontiers in Cardiovascular Drug Discovery: Volume 5
More LessFrontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The book series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.
The fifth volume of the series covers the following topics:
-The Lipid Hypothesis: From Resins to Proprotein Convertase Subtilisin/Kexin Type-9 Inhibitors
-The Role of SGLT2i in the Prevention and Treatment of Heart Failure
-Natural Products and Semi-Synthetic Compounds as Antithrombotics: A Review of the Last Ten Years (2009-2019)
-Transient Receptor Potential Channels: Therapeutic Targets for Cardiometabolic Diseases?
-Treatment of Raynauds Phenomenon
-Traditional Medicine Based Cardiovascular Therapeutics
-Cardiovascular Disease: A Systems Biology Approach
-
-
-
Frontiers in Cardiovascular Drug Discovery: Volume 6
More LessFrontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The book series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.
Volume 6 covers the following topics:
- Cardiovascular effects of ranolazine and the scope for translational research: a current review of literature
- Rho/Rho kinase signaling pathway and disease:
- Hibernation or transformation? Challenges in cardiovascular drug development
- New approaches in P2Y12 receptor blocker drugs use
- Pathophysiological links between diabetes and cardiovascular diseases: at the biochemical and molecular levels
-
-
-
Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 1
More LessFrontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimers Disease research.
-
-
-
Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 2
More LessFrontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer's disease and related disorders.
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimer's Disease research.
-
-
-
Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 3
More LessFrontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimers Disease research.
The third volume of this series features research on
-perfusional modifications in prodromal Alzheimer's disease,
-BACE inhibition treatment,
-frontotemporal dementia caused by progranulin mutations
-evidence-based treatment for psychological symptoms of Alzheimer’s Disease
-
-
-
Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 4
More LessFrontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimer’s Disease research.
The fourth volume of this series features research on
- Melatoninergic Pathways in Alzheimer's disease,
- Nutritional Approaches in Alzheimer’s disease prevention,
- Updates on drugs and strategies for Alzheimer’s disease prevention
-
-
-
Frontiers in Clinical Drug Research - Alzheimer Disorders: Volume 5
More LessFrontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series which covers recent topics related to understanding Alzheimer's disease (AD) that causes dementia and has a neurodegenerative effect on the brain. The disease affects memory, thought process, and language of affected individuals. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.
Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimer’s Disease research.
The fifth volume of this series features chapters covering critical discussions on AD management and new therapies. The topics reviewed in this volume include:
- Current concepts in management of AD
- The amyloid cascade hypothesis and stem cell-based AD therapy
- Phytochemicals targeting AD
- Dementia screening in primary clinical care settings
- Updates in dementia / AD clinical research and drug development
-